Everolimus for Compassionate Use in Multiple Basal Cell Carcinomas
Figure 2
Patient 4. (a) A facial basal cell carcinoma appeared after six months of everolimus treatment. (b) The lesion had disappeared after a further nine months of treatment (3 mg daily).
